Possibility of transkingdom gene therapy for Complex I diseases

Biochimica et Biophysica Acta - Bioenergetics

Volumn 1757, Issue 5-6, 2006, Pages 708-714

  Yagi, Takao ^a   Seo, Byoung Boo ^a   Nakamaru Ogiso, Eiko ^a   Marella, Mathieu ^a   Barber Singh, Jennifer ^a   Yamashita, Tetsuo ^a   Matsuno Yagi, Akemi ^a  

^a SCRIPPS RESEARCH INSTITUTE   (United States)

Author keywords

Adeno associated virus; Complex I; Gene therapy; Mitochondrial disease; NADH dehydrogenase; Parkinson's disease

Indexed keywords

ADENOVIRUS VECTOR; OXIDOREDUCTASE INHIBITOR; REACTIVE OXYGEN METABOLITE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE DEHYDROGENASE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE DEHYDROGENASE (UBIQUINONE); ROTENONE;

BRAIN; CELL BASED GENE THERAPY; CELL PROLIFERATION; CHEMOTHERAPY; COMPLEX I DEFICIENCY; DRUG EFFICACY; ENZYME ACTIVITY; ENZYME SUBUNIT; FUNGAL GENE; GENE EXPRESSION; GENE TARGETING; GENETIC TRANSDUCTION; HUMAN; INFLAMMATION; MAMMAL CELL; MITOCHONDRIAL MEMBRANE; MITOCHONDRIAL RESPIRATION; NONHUMAN; NONVIRAL GENE DELIVERY SYSTEM; PARKINSON DISEASE; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVIEW; RODENT; SACCHAROMYCES CEREVISIAE; SKELETAL MUSCLE; VIRAL GENE DELIVERY SYSTEM; VIRAL GENE THERAPY; YEAST;

ANIMALS; BRAIN; ELECTRON TRANSPORT COMPLEX I; GENE THERAPY; HUMANS; MITOCHONDRIAL DISEASES; MITOCHONDRIAL MEMBRANES; MUSCLE, SKELETAL; NADH DEHYDROGENASE; RATS; REACTIVE OXYGEN SPECIES; ROTENONE; SACCHAROMYCES CEREVISIAE PROTEINS; UNCOUPLING AGENTS;

ANIMALIA; MAMMALIA; RODENTIA; SACCHAROMYCES CEREVISIAE;

EID: 33745590836     PISSN: 00052728     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bbabio.2006.01.011     Document Type: Review

References (59)

1. Yagi T., Yano T., Di Bernardo S., and Matsuno-Yagi A. Procaryotic complex I (NDH-1), an overview. Biochim. Biophys. Acta 1364 (1998) 125
2. Yagi T., Seo B.B., Di Bernardo S., Nakamaru-Ogiso E., Kao M.C., and Matsuno-Yagi A. NADH dehydrogenases: from basic science to biomedicine. J. Bioenerg. Biomembr. 33 (2001) 233
3. Yagi T., Di Bernardo S., Nakamaru-Ogiso E., Kao M.C., Seo B.B., and Matsuno-Yagi A. NADH Dehydrogenase (NADH-Quinone Oxidoreductase). In: Zannoni D. (Ed). Respiration in Archaea and Bacteria. Advances in Photosynthesis and Respiration vol. 15 (2004), Kluwer Academic Publishers, Dordrecht 15-40
4. +-translocating NADH-quinone reductase of marine and moderately halophilic bacteria. In: Zannoni D. (Ed). Respiration in Archaea and Bacteria. Advance in Photosynthesis and Respiration (2004), Kluwer Academic Publishers, Dordrecht 155-174
5. Yagi T. Bacterial NADH-quinone oxidoreductases. J. Bioenerg. Biomembr. 23 (1991) 211
6. Yagi T., and Matsuno-Yagi A. The proton-translocating NADH-quinone oxidoreductase in the respiratory chain: the secret unlocked. Biochemistry 42 (2003) 2266
7. Fang J., and Beattie D.S. Novel FMN-containing rotenone-insensitive NADH dehydrogenase from Trypanosoma brucei mitochondria: isolation and characterization. Biochemistry 41 (2002) 3065
8. Bandeiras T.M., Salgueiro C.A., Huber H., Gomes C.M., and Teixeira M. The respiratory chain of the thermophilic archaeon Sulfolobus metallicus: studies on the type-II NADH dehydrogenase. Biochim. Biophys. Acta 1557 (2003) 13
9. Jaworowski A., Mayo G., Shaw D.C., Campbell H.D., and Young I.G. Characterization of the respiratory NADH dehydrogenase of Escherichia coli and reconstitution of NADH oxidase in ndh mutant membrane vesicles. Biochemistry 20 (1981) 3621
10. Melo A.M., Bandeiras T.M., and Teixeira M. New Insights into Type II NAD(P)H:Quinone Oxidoreductases. Microbiol. Mol. Biol. Rev. 68 (2004) 603
11. Fang J., and Beattie D.S. External alternative NADH dehydrogenase of Saccharomyces cerevisiae: a potential source of superoxide. Free Radical Biol. Med. 34 (2003) 478
12. Carroll J., Shannon R.J., Fearnley I.M., Walker J.E., and Hirst J. Definition of the nuclear encoded protein composition of bovine heart mitochondrial complex I: identification of two new subunits. J. Biol. Chem. 277 (2002) 50311
13. Paul C.P., Good P.D., Li S.X., Kleihauer A., Rossi J.J., and Engelke D.R. Localized expression of small RNA inhibitors in human cells. Mol. Ther. 7 (2003) 237
14. Guénebaut V., Schlitt A., Weiss H., Leonard K., and Friedrich T. Consistent structure between bacterial and mitochondrial NADH:ubiquinone oxidoreductase (complex I). J. Mol. Biol. 276 (1998) 105
15. Chomyn A., Mariottini P., Cleeter M.W.J., Ragan C.I., Matsuno-Yagi A., Hatefi Y., Doolittle R.F., and Attardi G. Six unidentified reading frames of human mitochondrial DNA encode components of the respiratory-chain NADH dehydrogenase. Nature 314 (1985) 591
16. Chomyn A., Cleeter M.W.J., Ragan C.I., Riley M., Doolittle R.F., and Attardi G. URF6, last unidentified reading frame of human mtDNA, codes for an NADH dehydrogenase subunit. Science 234 (1986) 614
17. +-translocating NADH-quinone oxidoreductase (NDH-1) of Paracoccus denitrificans: studies on topology and stoichiometry of the peripheral subunits. J. Biol. Chem. 274 (1999) 28606
18. Kao M.C., Di Bernardo S., Matsuno-Yagi A., and Yagi T. Characterization and topology of the membrane domain Nqo10 subunit of the proton-translocating NADH-quinone oxidoreductase of Paracoccus denitrificans. Biochemistry 42 (2003) 4534
19. Kao M.C., Di Bernardo S., Matsuno-Yagi A., and Yagi T. Characterization of the membrane domain Nqo11 subunit of the proton-translocating NADH-quinone oxidoreductase of Paracoccus denitrificans. Biochemistry 41 (2002) 4377
20. Di Bernardo S., Yano T., and Yagi T. Exploring the membrane domain of the reduced nicotinamide adenine dinucleotide-quinone oxidoreductase of Paracoccus denitrificans: characterization of the NQO7 subunit. Biochemistry 39 (2000) 9411
21. Ohnishi T. Iron-sulfur clusters semiquinones in Complex I. Biochim. Biophys. Acta 1364 (1998) 186
22. Rasmussen T., Scheide D., Brors B., Kintscher L., Weiss H., and Friedrich T. Identification of two tetranuclear FeS clusters on the ferredoxin-type subunit of NADH:ubiquinone oxidoreductase (complex I). Biochemistry 40 (2001) 6124
23. Nakamaru-Ogiso E., Yano T., Yagi T., and Ohnishi T. Characterization of the iron-sulfur cluster N7(N1c) in the subunit NuoG of the proton-translocating NADH-quinone oxidoreductase from Escherichia coli. J. Biol. Chem. 280 (2005) 301
24. Hinchliffe P., and Sazanov L.A. Organization of iron-sulfur clusters in respiratory complex I. Science 309 (2005) 771
25. Darrouzet E., Issartel J.P., Lunardi J., and Dupuis A. The 49-kDa subunit of NADH-ubiquinone oxidoreductase (Complex I) is involved in the binding of piericidin and rotenone, two quinone-related inhibitors. FEBS Lett. 431 (1998) 34
26. Schuler F., Yano T., Di Bernardo S., Yagi T., Yankovskaya V., Singer T.P., and Casida J.E. NADH-quinone oxidoreductase: PSST subunit couples electron transfer from iron-sulfur cluster N2 to quinone. Proc. Natl. Acad. Sci. U. S. A. 96 (1999) 4149
27. Gong X., Xie T., Yu L., Hesterberg M., Scheide D., Friedrich T., and Yu C.A. The ubiquinone-binding site in NADH:ubiquinone oxidoreductase from Escherichia coli. J. Biol. Chem. 278 (2003) 25731
28. Nakamaru-Ogiso E., Sakamoto K., Matsuno-Yagi A., Miyoshi H., and Yagi T. The ND5 subunit was labeled by a photoaffinity analogue of fenpyroximate in bovine mitochondrial complex I. Biochemistry 42 (2003) 746
29. 3H]dihydrorotenone. FEBS Lett. 219 (1987) 108
30. Schuler F., and Casida J.E. Functional coupling of PSST and ND1 subunits in NADH:ubiquinone oxidoreductase established by photoaffinity labeling. Biochim. Biophys. Acta 1506 (2001) 79
31. Green K., Brand M.D., and Murphy M.P. Prevention of mitochondrial oxidative damage as a therapeutic strategy in diabetes. Diabetes 53 Suppl. 1 (2004) S110-S118
32. Kervinen M., Patsi J., Finel M., and Hassinen I.E. Lucigenin and coelenterazine as superoxide probes in mitochondrial and bacterial membranes. Anal. Biochem. 324 (2004) 45
33. Janssen R.J., Van den Heuvel L.P., and Smeitink J.A. Genetic defects in the oxidative phosphorylation (OXPHOS) system. Expert Rev. Mol. Diagn. 4 (2004) 143
34. Schapira A.H.V. Human complex I defects in neurodegenerative diseases. Biochim. Biophys. Acta 1364 (1998) 261
35. Greenamyre J.T., Sherer T.B., Betarbet R., and Panov A.V. Complex I and Parkinson's disease. IUBMB Life 52 (2001) 135
36. Wallace D.C. The mitochondrial genome in human adaptive radiation and disease: on the road to therapeutics and performance enhancement. Gene 354 (2005) 169
37. de Grey A.D.N.J. Mitochondrial gene therapy: an arena for the biomedical use of inteins. Trends Biotechnol. 18 (2000) 394
38. Manfredi G., Fu J., Ojaimi J., Sadlock J.E., Kwong J.Q., Guy J., and Schon E.A. Rescue of a deficiency in ATP synthesis by transfer of MTATP6, a mitochondrial DNA-encoded gene, to the nucleus. Nat. Genet. 30 (2002) 394
39. Nagley P., Farrell L.B., Gearing D.P., Nero D., Meltzer S., and Devenish R.J. Assembly of functional proton-translocating ATPase complex in yeast mitochondria with cytoplasmically synthesized subunit 8, a polypeptide normally encoded within the organelle. Proc. Natl. Acad. Sci. U. S. A. 85 (1988) 2091
40. Kitajima-Ihara T., and Yagi T. Rotenone-insensitive internal NADH-quinone oxidoreductase of Saccharomyces cerevisiae mitochondria: the enzyme expressed in Escherichia coli acts as a member of the respiratory chain in the host cells. FEBS Lett. 421 (1998) 37
41. Moller I.M. Plant mitochondria and oxidative stress: electron transport, NADPH turnover, and metabolism of reactive oxygen species. Annu. Rev. Plant Physiol. Plant Mol. Biol. 52 (2001) 561
42. de Vries S., Van Witzenburg R., Grivell L.A., and Marres C.A. Primary structure and import pathway of the rotenone-insensitive NADH-ubiquinone oxidoreductase of mitochondria from Saccharomyces cerevisiae. Eur. J. Biochem. 203 (1992) 587
43. Marres C.A.M., de Vries S., and Grivell L.A. Isolation and inactivation of the nuclear gene encoding the rotenone-insensitive internal NADH:ubiquinone oxidoreductase of mitochondria from Saccharomyces cerevisiae. Eur. J. Biochem. 195 (1991) 857
44. Seo B.B., Kitajima-Ihara T., Chan E.K., Scheffler I.E., Matsuno-Yagi A., and Yagi T. Molecular remedy of complex I defects: rotenone-insensitive internal NADH-quinone oxidoreductase of Saccharomyces cerevisiae mitochondria restores the NADH oxidase activity of complex I-deficient mammalian cells. Proc. Natl. Acad. Sci. U. S. A. 95 (1998) 9167
45. Seo B.B., Matsuno-Yagi A., and Yagi T. Modulation of oxidative phospho-rylation of human kidney 293 cells by transfection with the internal rotenone-insensitive NADH-quinone oxidoreductase (NDI1) gene of Saccharomyces cerevisiae. Biochim. Biophys. Acta 1412 (1999) 56
46. Seo B.B., Wang J., Flotte T.R., Yagi T., and Matsuno-Yagi A. Use of the NADH-Quinone oxidoreductase (NDI1) gene of Saccharomyces cerevisiae as a possible cure for complex I defects in human cells. J. Biol. Chem. 275 (2000) 37774
47. Bai Y., Hajek P., Chomyn A., Chan E., Seo B.B., Matsuno-Yagi A., Yagi T., and Attardi G. Lack of complex I activity in human cells carrying a mutation in mtDNA-encoded ND4 subunit is corrected by the Saccharomyces cerevisiae NADH-quinone oxidoreductase (NDI1) gene. J. Biol. Chem. 276 (2001) 38808
48. Seo B.B., Nakamaru-Ogiso E., Flotte T.R., Yagi T., and Matsuno-Yagi A. A single-subunit NADH-quinone oxidoreductase renders resistance to mammalian nerve cells against complex I inhibition. Mol. Ther. 6 (2002) 336
49. Sherer T.B., Betarbet R., Testa C.M., Seo B.B., Richardson J.R., Kim J.H., Miller G.W., Yagi T., Matsuno-Yagi A., and Greenamyre J.T. Mechanism of toxicity in rotenone models of Parkinson's disease. J. Neurosci. 23 (2003) 10756
50. Fromenty B., and Pessayre D. Inhibition of mitochondrial beta-oxidation as a mechanism of hepatotoxicity. Pharmacol. Ther. 67 (1995) 101
51. Pessayre D., Mansouri A., and Fromenty B. Nonalcoholic steatosis and steatohepatitis: V. Mitochondrial dysfunction in steatohepatitis. Am. J. Physiol.: Gastrointest. Liver Physiol. 282 (2002) G193-G199
52. Schriner S.E., Linford N.J., Martin G.M., Treuting P., Ogburn C.E., Emond M., Coskun P.E., Ladiges W., Wolf N., Van Remmen H., Wallace D.C., and Rabinovitch P.S. Extension of murine lifespan by overexpression of catalase targeted to mitochondria. Science 308 (2005) 1909
53. Seo B.B., Nakamaru-Ogiso E., Cruz P., Flotte T.R., Yagi T., and Matsuno-Yagi A. Functional expression of the single subunit NADH dehydrogenase in mitochondria in vivo: a potential therapy for Complex I deficiencies. Hum. Gene Ther. 15 (2004) 887
54. Schapira A.H.V., Cooper J.M., and Morgan-Hughes J.A. Molecular basis of mitochondrial myopathies: polypeptide analysis in complex I deficiency. Lancet 1 (1988) 500
55. Betarbet R., Sherer T.B., MacKenzie G., Garcia-Osuna M., Panov A.V., and Greenamyre J.T. Chronic systemic pesticide exposure reproduces features of Parkinson's disease. Nat. Neurosci. 3 (2000) 1301
56. Alam M., and Schmidt W.J. Rotenone destroys dopaminergic neurons and induces parkinsonian symptoms in rats. Behav. Brain Res. 136 (2002) 317
57. Hoglinger G.U., Feger J., Prigent A., Michel P.P., Parain K., Champy P., Ruberg M., Oertel W.H., and Hirsch E.C. Chronic systemic complex I inhibition induces a hypokinetic multisystem degeneration in rats. J. Neurochem. 84 (2003) 491
58. Champy P., Melot A., Guérineau Eng V., Gleye C., Fall D., Höglinger G.U., Ruberg M., Lannuzel A., Laprévote O., Laurens A., and Hocquemiller R. Quantification of acetogenins in Annona muricata linked to atypical parkinsonism in guadeloupe. Mov. Disord. 20 (2005) 1629
59. Eschemann A., Galkin A., Oettmeier W., Brandt U., and Kerscher S. HDQ (1-hydroxy-2-dodecyl-4(1H)quinolone), a high affinity inhibitor for mitochondrial alternative NADH-dehydrogen. J. Biol. Chem. 280 (2005) 3138